IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.740
-0.080 (-9.78%)
At close: Nov 7, 2024, 4:00 PM
0.600
-0.140 (-18.91%)
After-hours: Nov 7, 2024, 5:25 PM EST
Company Description
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors.
The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.
It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors.
The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
IceCure Medical Ltd
| Country | Israel |
| Founded | 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 77 |
| CEO | Eyal Shamir |
Contact Details
Address: 7 Ha’Eshel Street, PO Box 3163 Caesarea, 3079504 Israel | |
| Phone | 972 4 623 0333 |
| Website | icecure-medical.com |
Stock Details
| Ticker Symbol | ICCM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001584371 |
| CUSIP Number | M53071136 |
| ISIN Number | IL0011224156 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eyal Shamir | Chief Executive Officer and Director |
| Ronen Tsimerman CPA | Chief Financial Officer and Chief Operating Officer |
| Tlalit Bussi Tel-Tzure | Vice President of Business Development and Global Marketing |
| Merav Nir Dotan | Vice President of Human Resources |
| Galit Malik | Vice President of Operations and Service |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 5, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Oct 21, 2024 | 6-K | Report of foreign issuer |
| Oct 15, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Oct 7, 2024 | 6-K | Report of foreign issuer |
| Sep 24, 2024 | 6-K | Report of foreign issuer |
| Sep 16, 2024 | 6-K | Report of foreign issuer |
| Sep 12, 2024 | 6-K | Report of foreign issuer |
| Aug 28, 2024 | 6-K | Report of foreign issuer |
| Aug 20, 2024 | 6-K | Report of foreign issuer |
| Aug 16, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |